Posted On:
May 18, 2008
Trasylol Maker, Bayer, Recalls Blood Clotting Med From US Market
Bayer, the maker of blood clotting drug, Trasylol, announced that it plans to recall what is left of the allegedly defective medication from the US Markets - this, according to the FDA. In November of 2007, Trasylol was suspended for use in heart surgery by the FDA after a Canadian clinical study showed a heightened risk of death versus too other drugs that are used to manage blood loss during surgery.
Trasylol was previously used by patients who were at a higher risk of blood loss during coronary artery bypass surgery.
If you or a loved one has been injured or killed by Trasylol or any other defective drug, I would invite you to visit my website www.samlevine.com or contact my office, Sam Levine, Attorney at Law.
Bookmark: 
